B Osterwalder

7.1k citations
78 papers · 4.9k · 2 hit papers · h-index 25

Impact in

  • Oncology top 0.5%
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Surgical Treatments
  • Dermatology top 0.5%
    • Chemotherapy-related skin toxicity

Papers in

    • Hematopoietic Stem Cell Transplantation 23
    • Blood groups and transfusion 5
    • Acute Myeloid Leukemia Research 5
    • Chronic Myeloid Leukemia Treatments 4
    • Colorectal Cancer Treatments and Studies 13
    • Cancer Treatment and Pharmacology 11
    • Cancer Immunotherapy and Biomarkers 5

B Osterwalder

73 papers receiving 4.6k citations

B Osterwalder's Hit Papers

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study 2001 · 919 citations
9190+9+18Years since publication250500750

Peers

B Osterwalder
Comparison fields: 5 of 108
  • Oncology 3.3k
  • Dermatology 515
  • Hematology 545
  • Cancer Research 477
  • Hepatology 202
Replace Jeffrey Crawford with:
Jeffrey Crawford United States
Gabriela Kornek Austria
Th. Wobbes Netherlands
A Mittelman United States
P. Kosmidis Greece
Ashley E. Winkler United States
A. B. Miller Canada
N. Tubiana-Mathieu France
Jean‐François Morère France
Paul S. Ritch United States
B Osterwalder relative to Jeffrey Crawford United States Jeffrey Crawford's profile →
Citations per field
00.5×3.4×
Jeffrey Crawford · 1×
Citations per year

Countries citing papers authored by B Osterwalder

Since Specialization
Citations

This map shows the geographic impact of B Osterwalder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Osterwalder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Osterwalder more than expected).

Fields of papers citing papers by B Osterwalder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Osterwalder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Osterwalder. The network helps show where B Osterwalder may publish in the future.

Co-authors

The 25 scholars most cited alongside B Osterwalder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B Osterwalder Line = papers co-authored together B Osterwalder links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study
Hit paper breakdown →
2001919
2
Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer
Hit paper breakdown →
1999671
3 2002436
4 2001348
5 2000270
6 2001263
7 1998229
8 1998224
9 2002159
10
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.
1998143
11 2001134
12 1981116
13 1983101
14 199493
15 200089
16
Treatment of severe aplastic anemia.
198680
17
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors.
199877
18 200266
19 201646
20
Bone marrow transplantation for chronic myeloid leukemia.
198444

About B Osterwalder

B Osterwalder is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 78 papers that have together received 4.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (23 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (11 papers), Blood groups and transfusion (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Acute Myeloid Leukemia Research (5 papers), Transplantation: Methods and Outcomes (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Oncology (3.3k citations), Dermatology (515 citations), Hematology (545 citations), Cancer Research (477 citations) and Hepatology (202 citations). B Osterwalder has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include T. Griffin, Aman U. Buzdar, Hans Ulrich Burger, Chris Twelves, Stephen E. Jones, Paulo M. Hoff, Jean A. Maroun, Walter Kocha, Bruno Reigner and Joanne L. Blum. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Cancer Research, European Journal of Cancer and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact